UBS Group
DARE icon

UBS Group’s Dare Bioscience DARE Stock Holding History

UBS Group’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$78.9K Buy
43,363
+22,448
+107% +$38.4K ﹤0.01% 7113
2025
Q4 		$40.4K Sell
20,915
-1,706
-8% -$3.4K ﹤0.01% 7340
2025
Q3 		$47.5K Buy
22,621
+7,613
+51% +$17.2K ﹤0.01% 7596
2025
Q2 		$35.9K Sell
15,008
-7,083
-32% -$20.7K ﹤0.01% 8038
2025
Q1 		$63.8K Sell
22,091
-10,302
-32% -$32K ﹤0.01% 7392
2024
Q4 		$101K Buy
32,393
+31,508
+3,560% +$109K ﹤0.01% 6868
2024
Q3 		$2.87K Sell
885
-7,366
-89% -$25.2K ﹤0.01% 8351
2024
Q2 		$33.3K Buy
8,251
+8,209
+19,545% +$39.8K ﹤0.01% 6998
2024
Q1 		$245 Sell
42
-675
-94% -$3.31K ﹤0.01% 8691
2023
Q4 		$2.66K Buy
717
+675
+1,607% +$3.08K ﹤0.01% 8076
2023
Q3 		$231 Hold
42
– – ﹤0.01% 8672
2023
Q2 		$455 Hold
42
– – ﹤0.01% 8228
2023
Q1 		$520 Sell
42
-2,285
-98% -$30.3K ﹤0.01% 8994
2022
Q4 		$23.2K Sell
2,327
-2,381
-51% -$26.6K ﹤0.01% 7497
2022
Q3 		$57K Buy
4,708
+4,666
+11,110% +$64.1K ﹤0.01% 6210
2022
Q2 		$1K Sell
42
-397
-90% -$5.97K ﹤0.01% 9844
2022
Q1 		$8K Sell
439
-822
-65% -$15.5K ﹤0.01% 8660
2021
Q4 		$30K Buy
1,261
+1,219
+2,902% +$25.1K ﹤0.01% 7393
2021
Q3 		$1K Sell
42
-872
-95% -$17.2K ﹤0.01% 9165
2021
Q2 		$21K Buy
914
+872
+2,076% +$14.9K ﹤0.01% 7274
2021
Q1 		$1K Hold
42
– – ﹤0.01% 8759
2020
Q4 		$1K Hold
42
– – ﹤0.01% 8206
2020
Q3 		$1K Hold
42
– – ﹤0.01% 7769
2020
Q2 		$0 Sell
42
-3,167
-99% -$38.8K ﹤0.01% 7995
2020
Q1 		$32K Buy
+3,209
New +$43.2K ﹤0.01% 6165
2019
Q3 		– Sell
-11
Closed – – 8036
2019
Q2 		$0 Sell
11
-595
-98% -$7.07K ﹤0.01% 7902
2019
Q1 		$10K Buy
606
+187
+45% +$2.18K ﹤0.01% 6800
2018
Q4 		$4K Buy
419
+394
+1,576% +$4.15K ﹤0.01% 7620
2018
Q3 		$0 Sell
25
-464
-95% -$6.25K ﹤0.01% 8017
2018
Q2 		$7K Buy
489
+445
+1,011% +$5.94K ﹤0.01% 7325
2018
Q1 		$0 Sell
44
-310
-88% -$6.27K ﹤0.01% 7865
2017
Q4 		$9K Sell
354
-38
-10% -$1.22K ﹤0.01% 7082
2017
Q3 		$14K Buy
392
+132
+51% +$6.47K ﹤0.01% 6695
2017
Q2 		$14K Buy
260
+83
+47% +$4.82K ﹤0.01% 6538
2017
Q1 		$17K Buy
177
+96
+119% +$13.9K ﹤0.01% 6252
2016
Q4 		$7K Buy
81
+39
+93% +$3.72K ﹤0.01% 7082
2016
Q3 		$5K Sell
42
-7
-14% -$1.57K ﹤0.01% 7119
2016
Q2 		$12K Sell
49
-9
-16% -$2.88K ﹤0.01% 6670
2016
Q1 		$18K Buy
58
+26
+81% +$7.33K ﹤0.01% 6281
2015
Q4 		$11K Hold
32
– – ﹤0.01% 7215
2015
Q3 		$14K Hold
32
– – ﹤0.01% 7010
2015
Q2 		$18K Sell
32
-11
-26% -$7.55K ﹤0.01% 6964
2015
Q1 		$47K Buy
43
+26
+153% +$25.2K ﹤0.01% 6110
2014
Q4 		$13K Buy
+17
New +$10.6K ﹤0.01% 8139

Other funds holding DARE

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

UBS Group's DARE Position: Q1 2026 in Review

UBS Group increased its Dare Bioscience (DARE) stake by 107% in Q1 2026, buying an estimated $38.4K and bringing the position to 43,363 shares worth $78.9K. The position accounts for ﹤0.01% of the portfolio, ranked #7113.

UBS Group first reported a position in DARE in Q4 2014 and has held it in 44 quarters since. The position peaked at $101K in Q4 2024. 25 funds tracked by Wall St. Rank hold DARE as of Q1 2026.

  • UBS Group held 43,363 shares of Dare Bioscience worth $78.9K as of Q1 2026.
  • UBS Group bought 22,448 Dare Bioscience shares in Q1 2026, an estimated $38.4K.
  • Dare Bioscience made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #7113 holding.
  • UBS Group first reported a position in Dare Bioscience in Q4 2014 and has held it in 44 quarters since.
  • UBS Group's Dare Bioscience position peaked at $101K in Q4 2024.
  • 25 funds tracked by Wall St. Rank held Dare Bioscience as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.